| 2026-05-06 |
详情>>
股本变动：
变动后总股本64152.10万股
|
| 2026-05-06 |
详情>>
业绩披露：
2026年一季报每股收益-0.01美元,归母净利润-364.2万美元,同比去年增长81.64%
|
| 2026-05-06 |
财报披露：
美东时间 2026-05-06 盘前发布财报
|
| 2026-04-07 |
股东大会：
将于2026-05-20召开股东大会
会议内容 ▼▲
- 1.To elect the three nominees for director named in the accompanying proxy statement (the “Proxy Statement”) to hold office as Class III members of the Board of Directors until the 2029 annual meeting of stockholders;
2.To approve the amendment and restatement of the Company's 2018 Equity Incentive Plan to increase the aggregate number of shares of common stock available for issuance thereunder by 4,500,000 shares and to make certain other changes thereto as described further in the accompanying Proxy Statement;
3.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the accompanying Proxy Statement;
4.To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2026;
5.To transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.
|
| 2026-03-31 |
详情>>
内部人交易：
Spiegel Robert J.股份增加5243.00股
|
| 2026-03-02 |
详情>>
业绩披露：
2025年年报每股收益-0.13美元,归母净利润-8350万美元,同比去年增长52.17%
|
| 2025-11-07 |
详情>>
业绩披露：
2025年三季报(累计)每股收益-0.08美元,归母净利润-5463.8万美元,同比去年增长63.38%
|
| 2025-08-06 |
详情>>
业绩披露：
2025年中报每股收益-0.05美元,归母净利润-3621万美元,同比去年增长70.51%
|
| 2025-05-07 |
详情>>
业绩披露：
2025年一季报每股收益-0.03美元,归母净利润-1983.5万美元,同比去年增长64.19%
|
| 2025-04-08 |
股东大会：
将于2025-05-21召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees for director named in the accompanying proxy statement (the “Proxy Statement”) to hold office as Class II members of the Board of Directors until the 2028 annual meeting of stockholders;
2.To approve an amendment to our 2018 Equity Incentive Plan to, among other items, increase the total number of shares of our common stock issuable thereunder by 20,000,000 shares;
3.To approve an amendment to our 2014 Employee Stock Purchase Plan to increase the number of shares of our common stock issuable thereunder by 6,000,000 shares;
4.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement;
5.To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2025;
6.To transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.
|
| 2025-02-27 |
详情>>
业绩披露：
2024年年报每股收益-0.27美元,归母净利润-1.75亿美元,同比去年增长5.19%
|
| 2024-11-07 |
详情>>
业绩披露：
2024年三季报(累计)每股收益-0.23美元,归母净利润-1.49亿美元,同比去年增长-12.91%
|
| 2024-08-08 |
详情>>
业绩披露：
2024年中报每股收益-0.19美元,归母净利润-1.23亿美元,同比去年增长-40.55%
|
| 2024-05-02 |
详情>>
业绩披露：
2024年一季报每股收益-0.09美元,归母净利润-5539万美元,同比去年增长-45.3%
|
| 2024-03-27 |
股东大会：
将于2024-05-09召开股东大会
会议内容 ▼▲
- 1.Election of the three nominees for director named in the accompanying proxy statement to hold office as Class I members of the Board of Directors until the 2027 annual meeting of stockholders;
2.Advisory vote to approve named executive officer compensation;
3.Ratification of Ernst & Young LLP as our independent registered public accounting firm.
|
| 2024-03-14 |
复牌提示：
2024-03-14 06:55:00 停牌，复牌日期 2024-03-14 16:25:00
|
| 2024-02-28 |
详情>>
业绩披露：
2023年年报每股收益-0.32美元,归母净利润-1.84亿美元,同比去年增长-29.76%
|
| 2023-04-12 |
股东大会：
将于2023-05-31召开股东大会
会议内容 ▼▲
- 1.Election of the two nominees for director named in the accompanying proxy statement to hold office as Class III members of the Board of Directors until the 2026 annual meeting of stockholders;
2.Approval to amend our Restated Certificate of Incorporation to increase the total number of authorized shares of our common stock from 675,000,000 to 1,350,000,000 shares;
3.Approval to amend our 2018 Equity Incentive Plan to, among other items, (i) increase the total number of shares of our common stock issuable thereunder by 43,360,000 shares, and (ii) modify the fungible plan design;
4.Advisory vote to approve the preferred frequency of holding future advisory votes on executive compensation;
5.Advisory vote to approve named executive officer compensation;
6.Ratification of Ernst & Young LLP as our independent registered public accounting firm.
|
| 2022-03-22 |
股东大会：
将于2022-05-10召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees for director named in the accompanying proxy statement (the “Proxy Statement”) to hold office as Class II members of the Board of Directors until the 2025 annual meeting of stockholders;
2.To approve an amendment to our 2018 Equity Incentive Plan to increase the number of shares of our common stock issuable thereunder by 11,000,000 shares;
3.To approve an amendment to our 2014 Employee Stock Purchase Plan to increase the number of shares of our common stock issuable thereunder by 1,000,000 shares;
4.To approve, on an advisory basis, the compensation of our named executive officers, as disclosed in the Proxy Statement;
5.To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as our independent registered public accounting firm for the fiscal year ending December 31, 2022;
6.To transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.
|
| 2021-09-06 |
温馨提示：
美股因劳工节，9月6日休市一天
|
| 2021-03-22 |
股东大会：
将于2021-05-11召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees for director named in the accompanying proxy statement (the “Proxy Statement”) to hold office as Class I members of the Board of Directors until the 2024 annual meeting of stockholders;
2.To approve an amendment to the Company’s Restated Certificate of Incorporation to increase the total number of authorized shares of the Company’s common stock from 450,000,000 to 675,000,000 shares;
3.To approve an amendment to the Company’s 2018 Equity Incentive Plan to, among other items, increase the number of shares of the Company’s common stock issuable thereunder by 12,500,000 shares;
4.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement;
5.To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2021;
6.To transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.
|
| 2020-04-14 |
股东大会：
将于2020-06-05召开股东大会
会议内容 ▼▲
- 1.To elect the three nominees for director named in the accompanying proxy statement (the “Proxy Statement”) to hold office as Class III members of the Board of Directors until the 2023 annual meeting of stockholders;
2.To approve an amendment to the Company’s 2018 Equity Incentive Plan to increase the number of shares of the Company’s Common Stock issuable thereunder by 5,700,000 shares;
3.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement;
4.To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2020;
5.To transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.
|
| 2019-04-22 |
股东大会：
将于2019-06-06召开股东大会
会议内容 ▼▲
- 1.election of the two nominees for director named in the accompanying proxy statement to hold office as Class II members of the Board of Directors until the 2022 annual meeting of stockholders;
2.approval to increase the total number of authorized shares of our common stock from 300,000,000 to 450,000,0000 shares;
3.advisory vote to approve named executive officer compensation;
4.ratification of Ernst & Young LLP as our independent registered public accounting firm.
5.To transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.
|
| 2018-03-30 |
股东大会：
将于2018-05-15召开股东大会
会议内容 ▼▲
- 1.To elect the two nominees for director named in the accompanying proxy statement (the “Proxy Statement”) to hold office as Class I members of the Board of Directors until the 2021 annual meeting of stockholders;
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement;
3.To approve the Geron Corporation 2018 Equity Incentive Plan;
4.To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2018;
5.To transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.
|
| 2017-03-24 |
股东大会：
将于2017-05-09召开股东大会
会议内容 ▼▲
- 1.To elect the three nominees for director named in the accompanying proxy statement, or the Proxy Statement, to hold office as Class III members of the Board of Directors until the 2020 annual meeting of stockholders;
2.To approve, on an advisory basis, the compensation of the Company’s named executive officers, as disclosed in the Proxy Statement;
3.To approve, on an advisory basis, the frequency of holding future advisory votes on executive compensation;
4.To ratify the selection by the Audit Committee of the Board of Directors of Ernst & Young LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2017;
5.To transact such other business as may properly come before the Annual Meeting or any postponement or adjournment thereof.
|